{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:09:34Z","timestamp":1790539774944,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Few literatures have evaluated the exact role of metabolomics in the identification process of potential biomarkers for acute kidney injury among the patients receiving renal transplantation. On top of this, the success of metabolomics in biomarker translation seems to lie in the robust quantitative method. As such, a single-center retrospective observational study was conducted enrolling 42 patients underwent renal transplantation with\/without acute kidney injury, as well as 24 healthy volunteers, in Shanghai Changzheng Hospital. Plasma amino acid metabolic patterns for the participants were investigated by targeted UHPLC-MS\/MS metabolic profiling. The most significant changes of the explored metabolites were related to the disturbance of tryptophan metabolism and arginine metabolism. Abnormal circulating tryptophan and symmetric dimethylarginine were identified to be potential biomarkers of acute kidney injury, combination of which showed a higher area under receiver-operator curve value (AUC\u2009=\u20090.901), improved sensitivity (0.889) and specificity (0.831) compared with creatinine only. Overall, these results revealed that targeted metabolomics analysis would be a potent and promising strategy for identification and pre-validation of biomarkers of acute kidney injury in renal transplantation patients.<\/jats:p>","DOI":"10.1038\/s41598-018-32958-2","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T14:14:04Z","timestamp":1537971244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Diagnostic value of plasma tryptophan and symmetric dimethylarginine levels for acute kidney injury among tacrolimus-treated kidney transplant patients by targeted metabolomics analysis"],"prefix":"10.1038","volume":"8","author":[{"given":"Feng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangxi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen\u2019an","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wansheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"key":"32958_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1053\/j.ajkd.2011.11.034","volume":"59","author":"A Mehrotra","year":"2012","unstructured":"Mehrotra, A. et al. Incidence and consequences of acute kidney injury in kidney transplant recipients. Am. J. Kidney Dis. 59, 558\u2013565 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"32958_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.semnephrol.2017.09.007","volume":"38","author":"D Marx","year":"2018","unstructured":"Marx, D. et al. Proteomics and Metabolomics for AKI Diagnosis. Semin. Nephrol. 38, 63\u201387 (2018).","journal-title":"Semin. Nephrol."},{"key":"32958_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","volume":"15","author":"DS Wishart","year":"2016","unstructured":"Wishart, D. S. Emerging applications of metabolomics in drug discovery and precision medicine. Nat. Rev. Drug Discov. 15, 473\u2013484 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"32958_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4161\/org.24322","volume":"9","author":"HI Wettersten","year":"2013","unstructured":"Wettersten, H. I. & Weiss, R. H. Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targets. Organogenesis 9, 11\u201318 (2013).","journal-title":"Organogenesis"},{"key":"32958_CR5","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00216-011-5245-3","volume":"401","author":"F Chen","year":"2011","unstructured":"Chen, F., Xue, J., Zhou, L., Wu, S. & Chen, Z. Identification of serum biomarkers of hepatocarcinoma through liquid chromatography\/mass spectrometry-based metabonomic method. Anal. & Bioanal. Chem. 401, 1899\u20131904 (2011).","journal-title":"Anal. & Bioanal. Chem."},{"key":"32958_CR6","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1039\/C4MB00729H","volume":"11","author":"E Scolamiero","year":"2015","unstructured":"Scolamiero, E. et al. Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism. Mol. Biosyst. 11, 1525\u20131535 (2015).","journal-title":"Mol. Biosyst."},{"key":"32958_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.clinbiochem.2014.08.020","volume":"47","author":"E Scolamiero","year":"2014","unstructured":"Scolamiero, E. et al. Maternal Vitamin B12 deficiency detected in expanded newborn screening. Clin. Biochem. 47, 312\u2013317 (2014).","journal-title":"Clin. Biochem."},{"key":"32958_CR8","doi-asserted-by":"publisher","first-page":"299S","DOI":"10.1093\/jn\/136.1.299S","volume":"136","author":"NJ Cano","year":"2006","unstructured":"Cano, N. J., Fouque, D. & Leverve, X. M. Application of branched-chain amino acids in human pathological states: renal failure. J. Nutr. 136, 299S\u2013307S (2006).","journal-title":"J. Nutr."},{"key":"32958_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jbiotec.2016.12.001","volume":"242","author":"F Maniga","year":"2017","unstructured":"Maniga, F. et al. The why and how of amino acid analytics in cancer diagnostics and therapy. J. Biotechnol. 242, 30\u201354 (2017).","journal-title":"J. Biotechnol."},{"key":"32958_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2215\/CJN.06000613","volume":"9","author":"F Duranton","year":"2014","unstructured":"Duranton, F. et al. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function. Clin. J. Am. Soc. Nephro. 9, 37\u201345 (2014).","journal-title":"Clin. J. Am. Soc. Nephro."},{"key":"32958_CR11","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3390\/ijms18081702","volume":"18","author":"J Rysz","year":"2017","unstructured":"Rysz, J., Glubabrz\u00f3zka, A., Franczyk, B., Jab\u0142onowski, Z. & Cia\u0142kowskarysz, A. Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome. Int. J. Mol. Sci. 18, 1702 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"32958_CR12","doi-asserted-by":"publisher","first-page":"e0169077","DOI":"10.1371\/journal.pone.0169077","volume":"12","author":"R Bassi","year":"2017","unstructured":"Bassi, R. et al. Metabolomic Profiling in Individuals with a Failing Kidney Allograft. PloS one 12, e0169077 (2017).","journal-title":"PloS one"},{"key":"32958_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.clinbiochem.2016.06.002","volume":"49","author":"J Klepacki","year":"2016","unstructured":"Klepacki, J. et al. Amino Acids in a Targeted Versus a Non-Targeted Metabolomics LC-MS\/MS Assay. Are the Results Consistent? Clin. Biochem. 49, 955\u2013961 (2016).","journal-title":"Clin. Biochem."},{"key":"32958_CR14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.4155\/bio-2016-0057","volume":"8","author":"Q Wang","year":"2016","unstructured":"Wang, Q. et al. Quantification of 18 amino acids in human plasma: application in renal transplant patient plasma by targeted UHPLC-MS\/MS. Bioanalysis 8, 1337\u20131351 (2016).","journal-title":"Bioanalysis"},{"key":"32958_CR15","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research: Rockville, MD. Guidance for Industry: Bioanalytical Method Validation (2013)."},{"key":"32958_CR16","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.bbadis.2013.03.009","volume":"1832","author":"X Zhang","year":"2013","unstructured":"Zhang, X. et al. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum. Biochim. Biophys. Acta 1832, 1207\u20131216 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"32958_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ab.2015.07.004","volume":"487","author":"H Sugimoto","year":"2015","unstructured":"Sugimoto, H., Kakehi, M. & Jinno, F. Bioanalytical method for the simultaneous determination of D- and L-serine in human plasma by LC\/MS\/MS. Anal. Biochem. 487, 38\u201344 (2015).","journal-title":"Anal. Biochem."},{"key":"32958_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpba.2017.03.034","volume":"140","author":"DZ Furtado","year":"2017","unstructured":"Furtado, D. Z. et al. Profiles of amino acids and biogenic amines in the plasma of Cri-du-Chat patients. J. Pharma. Biomed. Anal. 140, 137\u2013145 (2017).","journal-title":"J. Pharma. Biomed. Anal."},{"key":"32958_CR19","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.jasms.2009.04.020","volume":"20","author":"JY Moon","year":"2009","unstructured":"Moon, J. Y., Jung, H. J., Moon, M. H., Chung, B. C. & Man, H. C. Heat-Map Visualization of Gas Chromatography-Mass Spectrometry Based Quantitative Signatures on SteroidMetabolism. J. Am. Soc. Mass Spectrom. 20, 1626\u20131637 (2009).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"32958_CR20","first-page":"374","volume":"62","author":"D Tesfaye","year":"2008","unstructured":"Tesfaye, D. et al. Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference. J. Clin. Epidemiol. 62, 374\u2013379 (2008).","journal-title":"J. Clin. Epidemiol."},{"key":"32958_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.molmed.2008.04.003","volume":"14","author":"A May","year":"2008","unstructured":"May, A. & Wang, T. J. Biomarkers for cardiovascular disease: challenges and future directions. Trends Mol. Med. 14, 261\u2013267 (2008).","journal-title":"Trends Mol. Med."},{"key":"32958_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/MCO.0000000000000233","volume":"19","author":"JC Marini","year":"2016","unstructured":"Marini, J. C. Interrelationships between glutamine and citrulline metabolism. Curr. Opin. Clin. Nutr. Metab. Care 19, 62\u201366 (2016).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"32958_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.clnu.2008.03.010","volume":"27","author":"NE Deutz","year":"2008","unstructured":"Deutz, N. E. The 2007 ESPEN Sir David Cuthbertson Lecture: amino acids between and within organs. The glutamate-glutamine-citrulline-arginine pathway. Clin. Nutr. 27, 321\u2013327 (2008).","journal-title":"Clin. Nutr."},{"key":"32958_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jchromb.2012.11.034","volume":"913","author":"C Chiarla","year":"2013","unstructured":"Chiarla, C. & Giovannini, I. Citrulline and metabolomics in acute kidney injury. J Chromatogr. B Analyt. Technol. Biomed. Life Sci. 913, 137\u2013137 (2013).","journal-title":"J Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"32958_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nm1543","volume":"13","author":"J Leiper","year":"2007","unstructured":"Leiper, J. et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat. Med. 13, 198 (2007).","journal-title":"Nat. Med."},{"key":"32958_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.trsl.2013.04.005","volume":"162","author":"B Betz","year":"2013","unstructured":"Betz, B. et al. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency. Transl. Res. 162, 67\u201376 (2013).","journal-title":"Transl. Res."},{"key":"32958_CR27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1681\/ASN.2005101119","volume":"17","author":"SM BodeB\u00f6ger","year":"2006","unstructured":"BodeB\u00f6ger, S. M. et al. Symmetrical Dimethylarginine: A New Combined Parameter for Renal Function and Extent of Coronary Artery Disease. J. Am. Soc. Nephrol. 17, 1128\u20131134 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"32958_CR28","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1515\/cclm.2011.679","volume":"49","author":"E Schwedhelm","year":"2011","unstructured":"Schwedhelm, E. et al. Plasma symmetric dimethylarginine reference limits from the Framingham Offspring Cohort. Clin. Chem. Lab. Med. 49, 1907\u20131910 (2011).","journal-title":"Clin. Chem. Lab. Med."},{"key":"32958_CR29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1097\/TP.0000000000000205","volume":"98","author":"H Pihlstr\u00f8m","year":"2014","unstructured":"Pihlstr\u00f8m, H. et al. Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients. Transplantation 98, 1219 (2014).","journal-title":"Transplantation"},{"key":"32958_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1373\/clinchem.2010.150854","volume":"57","author":"A Meinitzer","year":"2011","unstructured":"Meinitzer, A. et al. Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin. Chem. 57, 112 (2011).","journal-title":"Clin. Chem."},{"key":"32958_CR31","first-page":"959","volume":"21","author":"JT Kielstein","year":"2008","unstructured":"Kielstein, J. T., Martenslobenhoffer, J., Vollmer, S. & Bodeb\u00f6ger, S. M. L-Arginine, ADMA, SDMA, creatinine, MDRD formula: detour to renal function testing. J. Nephrol. 21, 959 (2008).","journal-title":"J. Nephrol."},{"key":"32958_CR32","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1093\/ndt\/gfl292","volume":"21","author":"JT Kielstein","year":"2006","unstructured":"Kielstein, J. T., Salpeter, S. R., Bode-Boeger, S. M., Cooke, J. P. & Fliser, D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function\u2013a meta-analysis. Nephrol. Dial. Transplant. 21, 2446\u20132451 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"32958_CR33","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.3109\/0886022X.2013.828308","volume":"35","author":"RA Sukhovershin","year":"2013","unstructured":"Sukhovershin, R. A. & Gilinsky, M. A. The influence of acute renal injury on arginine and methylarginines metabolism. Ren. Fail. 35, 1404\u20131411 (2013).","journal-title":"Ren. Fail."},{"key":"32958_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/978-1-4684-5952-4_39","volume":"294","author":"RR Brown","year":"1991","unstructured":"Brown, R. R. et al. Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Adv. Exp. Med. Biol. 294, 425\u2013435 (1991).","journal-title":"Adv. Exp. Med. Biol."},{"key":"32958_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1373\/clinchem.2012.184598","volume":"59","author":"OA Aboud","year":"2013","unstructured":"Aboud, O. A. & Weiss, R. H. New opportunities from the cancer metabolome. Clin. Chem. 59, 138\u2013146 (2013).","journal-title":"Clin. Chem."},{"key":"32958_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","volume":"93","author":"N Stoy","year":"2010","unstructured":"Taylor, M. W. & Feng, G. S. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB. J. 5, 2516 (1991).","journal-title":"J. Neurochem."},{"key":"32958_CR37","doi-asserted-by":"publisher","first-page":"F565","DOI":"10.1152\/ajprenal.2000.279.3.F565","volume":"279","author":"K Saito","year":"2000","unstructured":"Saito, K. et al. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. Am. J. Physiol. Renal Physiol. 279, F565 (2000).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"32958_CR38","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/ndt\/gfn739","volume":"24","author":"JC Schefold","year":"2009","unstructured":"Schefold, J. C. et al. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol. Dial. Transplant. 24, 1901 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"32958_CR39","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3109\/0886022X.2013.790301","volume":"35","author":"J Zhao","year":"2013","unstructured":"Zhao, J. Plasma kynurenic acid\/tryptophan ratio: a sensitive and reliable biomarker for the assessment of renal function. Ren. Fail. 35, 648\u2013653 (2013).","journal-title":"Ren. Fail."},{"key":"32958_CR40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2478\/v10039-010-0015-6","volume":"55","author":"K Pawlak","year":"2010","unstructured":"Pawlak, K., My\u015bliwiec, M. & Pawlak, D. Kynurenine pathway - a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients. Adv. Med. Sci. 55, 196\u2013203 (2010).","journal-title":"Adv. Med. Sci."},{"key":"32958_CR41","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.ajkd.2013.02.349","volume":"61","author":"PM Palevsky","year":"2013","unstructured":"Palevsky, P. M. et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am. J. Kidney Dis. 61, 649\u2013672 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"32958_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum, J. A. & Lameire, N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit. Care 17, 204 (2013).","journal-title":"Crit. Care"},{"key":"32958_CR43","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.ebiom.2015.09.004","volume":"2","author":"Y Ni","year":"2015","unstructured":"Ni, Y. et al. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals. EBioMedicine 2, 1513\u20131522 (2015).","journal-title":"EBioMedicine"},{"key":"32958_CR44","first-page":"427","volume":"39","author":"MS Hawley","year":"1988","unstructured":"Hawley, M. S., Conway, J., Anderson, A. P. & Cudd, P. A. Part 5. Evaluation of Laboratory Measurements for Clinical Assessment of Kidney Disease. Am. J. Kidney Dis. 39, 427\u2013435 (1988).","journal-title":"Am. J. Kidney Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32958-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32958-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32958-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:08:46Z","timestamp":1671617326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32958-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["32958"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-32958-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,2]]},"assertion":[{"value":"24 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14688"}}